[1]孙姣 于晓红 尹晓盟.心室颤动导管消融治疗进展[J].心血管病学进展,2020,(10):1044.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.011]
 SUN Jiao,YU Xiaohong,YIN Xiaomeng.Catheter Ablation for Ventricular Fibrillation[J].Advances in Cardiovascular Diseases,2020,(10):1044.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.011]
点击复制

心室颤动导管消融治疗进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年10期
页码:
1044
栏目:
综述
出版日期:
2020-10-25

文章信息/Info

Title:
Catheter Ablation for Ventricular Fibrillation
作者:
孙姣 于晓红 尹晓盟
(大连医科大学附属第一医院心律失常科,辽宁 大连 116000)
Author(s):
SUN Jiao YU Xiaohong YIN Xiaomeng
(Department of Arrhythmia,The First Affiliated Hospital of Dalian Medical University,Dalian 116000,Liaoning,China)
关键词:
心室颤动心脏性猝死导管消融转子
Keywords:
Ventricular fibrillation Sudden cardiac death Catheter ablation Rotors
DOI:
10.16806/j.cnki.issn.1004-3934.2020.10.011
摘要:
心室颤动是心脏性猝死的主要原因之一,埋藏式心脏转复除颤器是现阶段心脏性猝死预防的主要措施,然而,埋藏式心脏转复除颤器并不能有效防止室颤的复发,患者仍有遭受电风暴或多次电击的风险。研究表明,导管消融技术成为室颤及心脏性猝死预防和治疗的新方式。早期室颤消融探索主要针对单一触发点的处理,目前针对室颤维持机制及基质改良的研究不断出现,转子消融亦成为行之有效的方法。现就室颤导管消融的临床现状及最新进展做一综述,用于指导临床治疗策略的制定。
Abstract:
Ventricular fibrillation is one of the leading causes of sudden cardiac death, and implantable cardioverter-defibrillator (ICD) is the main measure to prevent sudden cardiac death at the present stage . However,ICD do not prevent the recurrece of ventricular fibrillation effectively, and patients remain at risk of electrical storm or multiple electric shocks. Studies have shown that catheter ablation should be a new approach of prevention and treatment of ventricular fibrillation and sudden cardiac death. Early exploration of this subject was focused on single trigger factor .At present,research on the maintenance mechanism of ventricular fibrillation and substrate improvement has emerged constantly . Rotor ablation is also become an effective method. In this paper,the clinical status and recent progress of catheter ablation of ventricular fibrillation are reviewed to guide the development of clinical treatment strategies

参考文献/References:


[1] Neumar RW,Eigel B,Callaway CW,et al. American Heart Association response to the 2015 Institute of Medicine report on strategies to improve cardiac arrest survival[J]. Circulation,2015,132(11):1049-1070.

[2] Al-Khatib SM,Stevenson WG,Ackerman MJ,et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol,2018,72(14):e91-e220.

[3] European Heart Rhythm Association,Heart Rhythm Society,Zipes DP,et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)[J]. J Am Coll Cardiol 2006,48(5):e247-e346.

[4] Ha?ssaguerre M,Shoda M,Ja?s P,et al. Mapping and ablation of idiopathic ventricular fibrillation[J]. Circulation,2002,106(8):962-967.

[5] Knecht S,Ha?ssaguerre M,Sacher F,et al. Long-term follow-up of idiopathic ventricular fibrillation ablation:a multicenter study[J]. J Am Coll Cardiol,2009,54(6):522-528.

[6] van Herendael H,Zado ES,Haqqani H,et al. Catheter ablation of ventricular ?brillation:importance of left ventricular outflow tract and papillary muscle triggers[J]. Heart Rhythm 2014,11(4):566-573.

[7] Nademanee K,Veerakul G,Chandanamattha P,et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium[J]. Circulation,2011,123(12):1270-1279.

[8] 胡康新,潘洁,姚文亮. Brugada 综合征若干临床进展[J]. 心血管病学进展,2016,37(1):94-97.

[9] Shelke A,Tachil A,Saggu D,et al. Catheter ablation for electrical storm in Brugada syndrome:Results of substrate based ablation[J]. Indian Heart J,2018,70(2):296-302.

[10] Pappone C,Ciconte G,Manguso F,et al. Assessing the malignant ventricular arrhythmic substrate in patients with Brugada syndrome[J]. J Am Coll Cardiol,2018,71(15):1631-1646.

[11] Ha?ssaguerre M,Extramiana F,Hocini M,et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes[J]. Circulation,2003,108(8):925-928.

[12] Yap J,Tan VH,Hsu LF,et al. Catheter ablation of ventricular fibrillation storm in a long QT syndrome genotype carrier with normal QT interval[J]. Singapore Med J,2013,54(1):1-4.

[13] Sanchez-Munoz JJ,Garcuia-Alberola A,Martinez-Sanchez J,et al. Ablation of premature ventricular complexes triggering ventricular fibrillation in a patient with long QT syndrome[J]. Indian Pacing Electrophysiol J,2011,11(3):81-83.

[14] Tan VH,Yap J,Hsu LF,et al. Catheter ablation of ventricular fibrillation triggers and electrical storm[J]. Europace,2012,14(12):1687-1695.

[15] Srivathsan K,Gami AS,Ackerman MJ,et al. Treatment of ventricular fibrillation in a patient with prior diagnosis of long QT syndrome:importance of precise electrophysiologic diagnosis to successfully ablate the trigger[J]. Heart Rhythm,2007,4(8):1090-1093.

[16] Ha?ssaguerre M,Derval N,Sacher F,et al. Sudden cardiac arrest associated with early repolarization[J]. N Engl J Med,2008,358(19):2016-2023.

[17] Nademanee K,Haissaguerre M,Hocini M,et al. Mapping and ablation of ventricular fibrillation associated with early repolarization syndrome[J]. Circulation. 2019 Oct 29;140(18):1477-1490.

[18] B?nsch D,Oyang F,Antz M,et al. Successful catheter ablation of electrical storm after myocardial infarction[J]. Circulation,2003,108(24):3011-3016.

[19] Komatsu Y,Hocini M,Nogami A,et al. Catheter ablation of refractory ventricular fibrillation storm after myocardial infarction[J]. Circulation,2019,139(20):2315-2325.

[20] Marrouche NF,Verma A,Wazni O,et al. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy[J]. J Am Coll Cardiol,2004,43(9):1715-1720.

[21] Sinha AM,Schmidt M,Marschang H,et al. Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy[J]. Pacing Clin Electrophysiol,2009,32(3):286-290.

[22] Enjoji Y,Mizobuchi M,Shibata K,et al. Catheter ablation for an incessant form of antiarrhythmic drug resistant ventricular fibrillation after acute coronary syndrome[J]. Pacing Clin Electrophysiol,2006,29(1):102-105.

[23] Hayashi M,Miyauchi Y,Murata H,et al. Urgent catheter ablation for sustained ventricular tachyarrhythmias in patients with acute heart failure decompensation[J]. Europace,2014,16(1):92-100.

[24] Morawski S,Pruszkowska P,Sredniawa B,et al. Long-term outcome of catheter ablation and other form of therapy for electrical storm in patients with implantable cardioverter-defibrillators[J]. J Interv Card Electrophysiol,2017,50(3):227-234.

[25] Yokoshiki H,Mitsuyama H,Watanabe M,et al. Suppression of ventricular fibrillation by electrical modification of the Purkinje system in hypertrophic cardiomyopathy[J]. Heart Vessels,2014,29(5):709-717.

[26] Syed FF,Ackerman MJ,McLeod CJ,et al. Sites of successful ventricular fibrillation ablation in bileaflet mitral valve prolapse syndrome[J]. Circ Arrhythm Electrophysiol,2016;9.

[27] Nakabayashi K,Sugiura R,Oka T. Catheter ablation targeting Purkinje potentials controlled ventricular fibrillation in a patient with a malignant lymphoma occurring in the ventricular septum[J]. BMJ Case Rep,2015,2015:bcr2014209026.DOI:10.1136/bcr-2014-209026.

[28] Krummen DE,Hayase J,Morris DJ,et al. Rotor stability separates sustained ventricular fibrillation from self-terminating episodes in humans[J]. J Am Coll Cardiol,2014,63(24):2712-2721.

[29]Pandit SV,Jalife J. Rotors and the dynamics of cardiac fibrillation[J]. Circ Res,2013,112(5):849-862.

[30] Krummen DE,Hayase J,Vampola SP,et al. Modifying ventricular fibrillation by targeted rotor substrate ablation:proof-of-concept from experimental studies to clinical VF[J]. J Cardiovasc Electrophysiol,2015,26(10):1117-1126.

[31] Imnadze G ,Zerm T. Prevention of ventricular fibrillation through de-networking of the Purkinje system:proof-of-concept paper on the substrate modification of the Purkinje network[J]. Pacing Clin Electrophysiol,2019,42(10):1285-1290.

相似文献/References:

[1]刘颖,袁美锦.儿童与青少年心脏性猝死的病因和预防[J].心血管病学进展,2019,(6):935.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.024]
 LIU Ying,YUAN Meijin.Causes and Prevention of Sudden Cardiac Death in Children and Adolescents[J].Advances in Cardiovascular Diseases,2019,(10):935.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.024]
[2]王宇 周思维 张莎 吴弘.植入型心律转复除颤器在心肌梗死后心脏性猝死中的研究进展[J].心血管病学进展,2020,(1):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
 WANG Yu,ZHOU Siwei,ZHANG Sha,et al.Implantable Cardioverter Defibrillator in Sudden Cardiac Death after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(10):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
[3]鲁星琴 莫乔莹 陈凤梅 姚亚丽.睡眠呼吸障碍与心力衰竭并发心房颤动的相关性研究现状[J].心血管病学进展,2020,(2):182.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.021]
 LU Xingqin,MO Qiaoying,CHENG Fengmei,et al.Research Status of Association Between Sleep-disordered Breathing and Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2020,(10):182.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.021]
[4]张琼月 甘华.血液透析患者发生心脏性猝死的易患因素[J].心血管病学进展,2020,(7):738.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.016]
 ZHANG Qiongyue,GAN Hua.Risk Factors for Sudden Cardiac Death in Hemodialysis Patients[J].Advances in Cardiovascular Diseases,2020,(10):738.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.016]
[5]王思博 王连生.心肌梗死后室性心律失常的治疗进展[J].心血管病学进展,2021,(6):481.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.001]
 WANG SiboWANG Liansheng.Treatment of Ventricular Arrhythmias after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(10):481.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.001]

更新日期/Last Update: 2020-12-21